Healthy Aging Resources to Thrive (HART)

Status Completed

Clinical Trial Summary

Healthy Aging Resources to Thrive (HART) uses a rigorous two-stage randomized control design, adapted and refined based on pilot studies, to test a novel intervention to reduce sitting time in older adults. Half the participants will be randomized to the intervention aimed at decreasing sitting time, and the other half will be randomized to a healthy living control that does not focus on reduced sitting time. After 6 months, the intervention group will be further randomized so that half continue with the intervention and the other half receive no further intervention. All participants will be followed for 12 months.

Clinical Trial Description

Healthy Aging Resources to Thrive (HART) is a two-stage randomized controlled trial (RCT) of adults over age 60 with obesity to determine the efficacy of a novel sitting-reduction intervention and its impact on cardiometabolic risk markers. Participants will be randomized to a 6-month sitting reduction intervention (termed I-STAND) or healthy-living attention control (Stage 1). All participants will be mailed a scale and a blood pressure monitor (to keep) which will be used during the phone-based measurement visits at Baseline, 3, 6 and 12 months. All participants will have phone-based Coaching sessions. After 6 months, I-STAND participants will be re-randomized to receive either booster sessions or no further intervention (Stage 2). Attention control participants will receive no further intervention. All participants will be followed for 12 months total with phone-based assessments at baseline, 3, 6, and 12 months. Primary outcomes are reduction in sitting time at 6 months, objectively measured using the activPAL device, and blood pressure. The design will answer novel questions about the impact of sitting reduction on cardiometabolic risk markers as well as maintenance of sitting reduction. UPDATE: As of 3/31/31, (final year 5) of the study, participants randomized to the i-STAND intervention will no longer be re-randomized at 6 months. We will no longer follow participants to the 12-month timepoint & will end all activities after 6-months. ;

Study Design

Related Conditions & MeSH terms

Sedentary Lifestyle

Clinical Trial Details

NCT number	NCT03739762
Study type	Interventional
Source	Kaiser Permanente
Contact
Status	Completed
Phase	N/A
Start date	February 5, 2019
Completion date	March 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02385591` - Innovative Physical Activity Interventions for Overweight Latinos	N/A
Completed	`NCT02672215` - RCT Computer-tailored Intervention on Workplace Sitting	N/A
Completed	`NCT02994134` - Exercise, Cognitive Function and Neuroplasticity in Healthy Adults	N/A
Completed	`NCT03305731` - Activating Behavior for Lasting Engagement After Stroke	N/A
Recruiting	`NCT04195165` - The Effect of Sitting and Moderate Exercise on Plasma Insulin and Glucose Responses to an Oral Glucose Tolerance Test	N/A
Completed	`NCT03119610` - The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity	Phase 1/Phase 2
Active, not recruiting	`NCT02467881` - Physical Activity and Sedentary Behavior Change; Impact on Lifestyle	N/A
Terminated	`NCT02254902` - Physical Activity and Education Program for Somali Women	N/A
Completed	`NCT02342301` - Cardiometabolic Response to Sit-stand Workstations.	N/A
Completed	`NCT01975870` - A stAPP to a Healthier Lifestyle	N/A
Completed	`NCT02024061` - Treatment of Pediatric Obesity (TOP) - A Multidisciplinary Approach Involving Adolescents and Their Peers	N/A
Completed	`NCT02960750` - Effectiveness of a Workplace "Sit Less and Move More" Web-based Program in Spanish Office Employees (Walk@WorkSpain)	N/A
Completed	`NCT00183014` - Caminemos! Trial to Increase Walking Among Sedentary Older Latinos	N/A
Completed	`NCT04049162` - Blueberry Enhances Activity and Cognition Through Increased Vascular Efficiency	N/A
Completed	`NCT03283904` - Active Schools: Skelmersdale	N/A
Completed	`NCT03694951` - The Effect of Experimentally Decreasing Sedentary Behaviour on Subjective Well-being	N/A
Enrolling by invitation	`NCT04019119` - Digital Intervention for the Modification of Lifestyles (iGame)	N/A
Completed	`NCT03109535` - MapTrek for Sedentary Workers	N/A
Completed	`NCT03993652` - Kids FIRST: Family-based Intervention to Reduce Snacking and Screen Time in Children	N/A
Completed	`NCT00891514` - Trial of Aerobic Exercise Training in Stroke Survivors	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Healthy Aging Resources to Thrive (HART) — HART

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms